THE RELATIONSHIP OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND CELLULAR LINK HEMOSTASIS IN PATIENTS DURING THE RECOVERY PERIOD OF STROKE

封面

如何引用文章

全文:

详细

A study of induced platelet aggregation, the level of markers of immune inflammation, endothelial dysfunction in patients during the recovery period of stroke. It has been established that both in the early and in the late post-stroke period, signs of chronic immune inflammation associated with endothelial dysfunction persist. The risk groups for recurrent stroke in patients during the recovery period were identified.

作者简介

E. Soloveva

Pirogov Russian National Research Medical University (RNRMU)

编辑信件的主要联系方式.
Email: ellasolovieva@yandex.ru

MD, PhD, Professor of the Department of Neurology, Faculty of Pediatric Surgery, Head of the Laboratory for Biomedical Research in Neurology,

Moscow

俄罗斯联邦

O. Baranova

Pirogov Russian National Research Medical University (RNRMU)

Email: fake@neicon.ru

PhD, Senior Researcher, Scientific Research Laboratory of Biomedical Research in Neurology,

Moscow

俄罗斯联邦

A. Chekanov

Pirogov Russian National Research Medical University (RNRMU)

Email: fake@neicon.ru

Ph.D., Senior Researcher, Scientific Research Laboratory of Biomedical Research in Neurology,

Moscow

俄罗斯联邦

E. Tyutyumova

Pirogov Russian National Research Medical University (RNRMU)

Email: fake@neicon.ru

Post-Graduate Student, Department of Neurology, FDPO, doctor 1 neurological department of the Central Clinical Hospital of St. Alexis of Moscow,

Moscow

俄罗斯联邦

A. Fedin

Pirogov Russian National Research Medical University (RNRMU)

Email: fake@neicon.ru

Doctor of Medical Sciences, Professor, Head of the Department of Neurology, FDPO,

Moscow

俄罗斯联邦

参考

  1. Суслина З. А., Танашян М. М., Лагода О. В. Атеросклероз и ишемические нарушения мозгового кровообращения. Атеротромбоз. 2009, 3(2), 60–67.
  2. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack2008. Cerebrovasc Dis. 2008, 25(5), 457–507. doi: 10.1159/000131083.
  3. Панченко Е. П. Атеротромбоз: механизмы развития и реально проводимая терапия. Атеротромбоз. 2008, 1, 22–27.
  4. Максимова М. Ю., Комелькова Л. В., Охтова Ф. Р. Факторы межклеточного взаимодействия при ишемическом инсульте. Журнал неврологии и психиатрии им. С. С. Корсакова. 2014, 2, 15–20.
  5. Fathollahi A., Massoud A., Amirzargar A. A., Aghili B., Nasli Esfahani E., Rezaei N. sICAM-1, sVCAM-1 and sE-Selectin Levels in Type 1 Diabetes. Fetal Pediatr Pathol. 2018, 37(1), 69–73. doi: 10.1080/15513815.2017.1405467.

版权所有 © Soloveva E.Y., Baranova O.A., Chekanov A.V., Tyutyumova E.A., Fedin A.I., 2019

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##